InvestorsHub Logo
Followers 61
Posts 7514
Boards Moderated 2
Alias Born 02/10/2010

Re: None

Wednesday, 12/07/2016 11:31:12 AM

Wednesday, December 07, 2016 11:31:12 AM

Post# of 6599
Some Good News here for a change:

http://seekingalpha.com/pr/16687473-international-stem-cell-corporation-announces-second-patient-parkinson-s-disease-treated

International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial

Wed December 7, 2016 8:30 AM|GlobeNewswire|About: ISCO

GlobeNewswire
CARLSBAD, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced the treatment of the second patient in the Australian trial for Parkinson’s Disease. The patient was injected with 30,000,000 ISC-hpNSC® cells and is currently recovering.

The surgery was performed on Sunday, December 4, at the Royal Melbourne Hospital (RMH), the same site as the first treatment. The operation was successfully performed without complications by the team of the RMH neurosurgeons.

“We are very encouraged by how the clinical trial is moving ahead,” commented Russell Kern, PhD, executive vice president and chief scientific officer of ISCO. “The second operation was delayed by a supply chain disruption of equipment critical to the operation, but we have managed to fix the issue and bring the clinical trial back on track. In addition, we have identified patients to be enrolled in the trial and are working to get them treated in 2017.”,...

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ISCO News